<DOC>
	<DOCNO>NCT00252005</DOCNO>
	<brief_summary>The purpose clinical research study assess efficacy safety 3 dos apixaban 5 mg twice day , 10 mg twice day 20 mg daily versus conventional treatment low molecular weight heparin fondaparinux vitamin K antagonist treatment subject acute symptomatic deep-vein thrombosis .</brief_summary>
	<brief_title>Oral Direct Factor Xa-inhibitor Apixaban Patients With Acute Symptomatic Deep-vein Thrombosis-The Botticelli DVT Study</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Factor Xa Inhibitors</mesh_term>
	<criteria>1 . Subjects must willing able give write informed consent . 2 . Confirmed acute symptomatic DVT , i.e. , proximal vein extensive calfvein thrombosis , involve least upper third part deep calf vein ( trifurcation area ) without concomitant symptomatic PE . 3 . Women men , age 18 ( legal age consent ) 90 . Women childbearing potential ( WOCBP ) must use adequate method contraception avoid pregnancy throughout study 1 week study manner risk pregnancy minimize . WOCBP include female experienced menarche undergone successful surgical sterilization ( hysterectomy , bilateral tubal ligation bilateral oophorectomy ) postmenopausal [ define amenorrhea 12 consecutive month ; woman hormone replacement therapy ( HRT ) document serum follicle stimulate hormone ( FSH ) level &gt; 35mIU/mL ] . Even woman use oral , implanted , injectable contraceptive hormone mechanical product intrauterine device barrier method ( diaphragm , condom , spermicide ) prevent pregnancy practice abstinence partner sterile ( e.g. , vasectomy ) , consider child bear potential . WOCBP must negative serum urine pregnancy test ( minimum sensitivity 25IU/L equivalent unit HCG ) within 24 hour prior start study medication . 1 . Women pregnant breastfeeding . 2 . Women positive pregnancy test enrollment prior study drug administration . 3 . More 24 hour prerandomization treatment therapeutic dosage unfractionated heparin ( UFH ) , low molecular weight heparin ( LMWH ) fondaparinux single start dose vitamin K antagonist ( VKA ) prior randomization . 4 . Uncontrolled hypertension : systolic blood pressure &gt; 200 mm Hg diastolic blood pressure &gt; 110 mm Hg . 5 . Creatinine clearance &lt; 30 mL/min 6 . Impaired liver function ( ALT &gt; 3 x ULN ) 7 . Use ASA &gt; 165 mg/day 8 . WOCBP unwilling unable use acceptable method birth control avoid pregnancy entire study period 1 week study . 9 . Azole antifungal ( e.g. , ketoconazole ) , HIV protease inhibitor ( e.g. , ritonavir ) macrolide antibiotic ( e.g. , erythromycin ) . NOTE : topical azole antifungal agent permit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>